Determinants of resistance to engineered T cell therapies targeting CD19 in large B cell lymphomas
In: Cancer Cell, Vol. 41 (2023), No. 1, pp. 210 - 225.e5
2023article/chapter in journalClosed access
MedicineFaculty of Medicine » Essen University Hospital » Clinic for HematologyScientific institutes » Center of Medical Biotechnology (ZMB)
Related: 1 publication(s)
Title in English:
Determinants of resistance to engineered T cell therapies targeting CD19 in large B cell lymphomas
Author:
Sworder, Brian J.
- LSF ID
- 12928
- ORCID
- 0000-0003-2230-3873
- Other
- connected with university
- GND
- 1073185001
- LSF ID
- 14454
- ORCID
- 0000-0002-4034-9472
- Other
- connected with university
- Other
- corresponding author
Year of publication:
2023
Open Access?:
Closed access
Web of Science ID
PubMed ID
Scopus ID
Language of text:
English
Keyword, Topic:
cell-free DNA ; chimeric antigen receptor T cells ; circulating tumor DNA ; ctDNA ; genomics ; immunotherapy ; large B cell lymphoma ; MRD ; oncology ; precision medicine